25th Annual Meeting of the European Charcot Foundation, November 30 till December 2, 2017, Baveno (IT)
 
Posters presented by Young Investigators (born in 1982 or after):

Basic Studies
DERDELINCKX Judith Belgium Multi-epitope-engineered tolerogenic dendritic cells effectively dampen EAE
View poster     -     Abstract     -     View poster presentation
FISCHBACH Felix Germany Integrated stress response (ISR) regulates oligodendrocyte death and axonal damage in the cuprizone model
View poster     -     Abstract
HOFER Livia Austria T Cell Epitope Mapping of AQP4 and MOG in patients with NMOSD
View poster     -     Abstract 
KALININ Ivan Russia Kappa free light chain concentrations correlate with brain atrophy in multiple sclerosis
View poster     -     Abstract     -     View poster presentation
KHIZANISHVILI Nino Georgia Changes of free radicals in early progression of multiple sclerosis
View poster     -     Abstract
NEDELCU Julia Germany Segmental demyelination of internodes triggers mitochondrial redistribution
View poster     -     Abstract
PEETERS Liesbet Belgium FAIR data for next generation management
View poster     -     Abstract     -     View poster presentation
REINBACH Christin Rebecca Germany Immunologically relevant genes are as well expressed by glia cells: a strong support of the hypothesis that multiple sclerosis is a primary degenerative disorder
View poster     -     Abstract
SCHWEIGER Felix Germany Compact Myelin Detachment after metabolic Oligodendrocyte injury
View poster     -     Abstract 
STEPANOVA Aleksandra Russia Сonnection between LMCE formation and disturbances in peripheral blood B-cells’ subsets.
View poster     -     Abstract     -     View poster presentation
TESKE Nico Germany Chemical hypoxia-induced unfolded protein response activation in oligodendrocytes is mediated by the transcription factor nuclear factor (erythroid-derived 2)-like 2 (NRF2)
View poster     -     Abstract 

Clinical
BRITZE Josefine Denmark Multiple sclerosis or Susac syndrome – can you tell the difference?
View poster     -     Abstract
CONGIU Martina Italy Impact of fatigue and depression on motor rehabilitation outcomes in progressive multiple sclerosis
View poster     -     Abstract
KHIZANISHVILI Nino Georgia Cognitive status impairment and depression rate in multiple sclerosis (MS) patients
View poster     -     Abstract  
TAZZA Francesco Italy Beneficial effects of adapted physical activity on physical and cognitive aspects of multiple sclerosis: Results of a preliminary study carried out in collaboration with the Italian Multiple Sclerosis Association - Perugia section
Abstract
ZARKALI Angeliki United Kingdom Multiple sclerosis put on pause: cardiogenic syncope with prolonged sinus pauses secondary to demyelinating brainstem lesions
Abstract

Epidemiology
BARONCINI Damiano Italy The impact of menopause on multiple sclerosis: a multicentre retrospective observational study
View poster     -     Abstract
BEZZINI Daiana Italy Multiple sclerosis incidence in Tuscany from administrative data
View poster     -     Abstract     -     View poster presentation
CHENG Stephen Wing Ho Hong Kong Conversion of clinically isolated syndrome into multiple sclerosis and neuromyelitis optica spectrum disorders in Hong Kong – a 5-year prognosis study
View poster     -     Abstract     -     View poster presentation
GOI Leise Brazil Limited NMOSD phenotypes in patients with low anti-AQP4+ titers
View poster     -     Abstract
MESSINA Silvia United Kingdom Does smoking affect disability in AQP4 antibody positive NMOSD and MS patients, and what is the mechanism?
Abstract
RODRIGUEZ Emmanuel Mexico Cerebrospinal liquid findings in Mexican patients with anti-NMDA encephalitis.
View poster     -     Abstract     -     View poster presentation
ROMEO Marzia Italy Cesarean delivery and artificial lactation are associated with an earlier age of disease onset in multiple sclerosis
Abstract

Investigations
CLARKE Margareta United Kingdom The central vein sign in multiple sclerosis: a real-life multi-centre MAGNIMS study
View poster     -     Abstract
DALLA COSTA Gloria Italy Serum Neurofilament light chain levels increase at the onset of PML in Natalizumab treated MS patients
View poster     -     Abstract
DE SANTIAGO Luis Spain Applicability of automatic classification of multifocal visual evoked potentials signals in multiple sclerosis assessment.
View poster     -     Abstract
GUERRIERI Simone Italy Visual pathway involvement in progressive multiple sclerosis: demyelination and neurodegeneration are more prominent in secondary progressive than primary progressive patients
Abstract
HUANG Su-Chun Italy Reduced reflectance of retinal nerve fiber layer as a marker of microtubule axonal damage in experimental autoimmune encephalomyelitis
View poster     -     Abstract
MARENNA Silvia Italy Visual evoked potentials and optical coherence tomography to detect optic neuritis in C57BL/6
View poster     -     Abstract
PISA Marco Italy Motor evoked potentials as a clinically relevant outcome in progressive MS
Abstract
SAMOYLOVA Nina Russia Functional changes in brain cortex in multiple sclerosis patients with cognitive disorders and different types of disease measured by means of positron emission tomography
View poster     -     Abstract   
SIGNORIELLO Elisabetta Italy Adiponectin as a possible biomarker in multiple sclerosis
View poster     -     Abstract
VERMEULEN Sébastien Belgium Cortical grey matter ratio differentiates relapsing remitting multiple sclerosis from secondary progressive multiple sclerosis
View poster     -     Abstract     -     View poster presentation
ZANETTA Chiara Italy Higher sensitivity of visual evoked potentials compared to optical coherence tomography in clinically isolated syndrome
Abstract

Treatments
BAJRAMI Albulena Italy The effect of Fingolimod on grey matter damage, focal and diffuse, in RRMS patients
View poster     -     Abstract
CERONIE Bryan United Kingdom Cladribine controls multiple sclerosis via memory B cell depletion
View poster     -     Abstract     -     View poster presentation
DURÃES João Portugal Rituximab in multiple sclerosis: importance of the dosing regimen
View poster     -     Abstract     -     View poster presentation
KANEKO Kimihiko Japan Efficacy of interferon-β for demyelinating disorders with myelin oligodendrocyte glycoprotein antibody
View poster     -     Abstract     -    View poster presentation
LEFORT Mathilde France Effect of early treatment initiation in real-world settings on disability progression: A series of 281 relapsing-remitting multiple sclerosis patients, Rennes, France
View poster     -     Abstract     -     View poster presentation
MAES Deborah Belgium Treatment and CSYNC(TM) satisfaction with glatiramer acetate 20mg/ml once daily vs. glatiramer acetate 40mg/ml three times a week in RRMS patients: a patient survey
View poster     -     Abstract
SANGALLI Francesca Italy Natalizumab treatment for multiple sclerosis: a 10-years monocentric experience
Abstract